CAMESA helps parents and doctors manage the side effects of
second generation antipsychotics in children. The Canadian
Alliance for Monitoring Effectiveness and Safety of
Antipsychotics in Children (CAMESA) guidelines were developed by
a group of physicians, health professionals and researchers from
across Canada, with the support of the Canadian Institutes of
Health Research. The goal of the CAMESA guidelines is to improve
the quality of life of children with mental health disorders by
promoting antipsychotic drug safety. There are three CAMESA
guidelines: - How to monitor antipsychotic drug safety - How to
manage or treat metabolic complications of antipsychotic
medications if they occur (such as weight gain, or elevated
cholesterol) - How to manage or treat extrapyramidal
complications of antipsychotic medications if the occur
(involuntary movements) The guidelines synthesize research
findings and provide recommendations on how to perform these
tasks.